Index of reports
> Cases with Stem Cell Transplant (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Infergen (Interferon Alfacon-1) where reactions include stem cell transplant. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Infergen side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2011-12-02
Patient: 49 year old male
Reactions: Stem Cell Transplant, Neoplasm Progression, Multiple Myeloma, Refractory Cytopenia With Multilineage Dysplasia
Drug(s) suspected as cause:
Cisplatin
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 10 cycles
Indication: Multiple Myeloma
Cytarabine
Indication: Multiple Myeloma
Start date: 1998-11-01
Ifosfamide
Indication: Multiple Myeloma
Carmustine
Indication: Multiple Myeloma
Start date: 1998-11-01
Etoposide
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Infergen
Dosage: 3 x 10 iu thrice weekly
Indication: Multiple Myeloma
End date: 2005-09-01
Prednisone TAB
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Possible Infergen side effects in 49 year old male
Reported by a health professional (non-physician/pharmacist) from Greece on 2011-11-23
Patient: 49 year old male
Reactions: Stem Cell Transplant, Neoplasm Progression, Refractory Cytopenia With Multilineage Dysplasia, Multiple Myeloma
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Prednisone TAB
Indication: Multiple Myeloma
Infergen
Dosage: 3 x 10 iu thrice weekly
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Cytarabine
Indication: Multiple Myeloma
Start date: 1998-11-01
Carmustine
Indication: Multiple Myeloma
Start date: 1998-11-01
Ifosfamide
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Melphalan Hydrochloride
Dosage: 10 cycles
Indication: Multiple Myeloma
|